BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
3.565
-0.015 (-0.42%)
Apr 2, 2025, 1:07 PM EDT - Market open

BioAge Labs Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Net Income
-71.11-63.85-39.72
Depreciation & Amortization
0.170.160.13
Loss (Gain) From Sale of Assets
0.06--
Stock-Based Compensation
6.983.022.54
Other Operating Activities
1.2116.60.08
Change in Accounts Payable
0.01-0.390.99
Change in Unearned Revenue
9.193.31-
Change in Other Net Operating Assets
1.983.79-0.2
Operating Cash Flow
-51.52-37.36-36.18
Capital Expenditures
-0.37-0.17-0.1
Investment in Securities
--0.1-
Investing Cash Flow
-0.37-0.27-0.1
Short-Term Debt Issued
-23.5-
Long-Term Debt Issued
-12.52.5
Total Debt Issued
-362.5
Long-Term Debt Repaid
-6-1-
Net Debt Issued (Repaid)
-6352.5
Issuance of Common Stock
222.2500.04
Other Financing Activities
-5.05-0.06-0.05
Financing Cash Flow
381.234.942.5
Foreign Exchange Rate Adjustments
0.08-0.25
Net Cash Flow
329.39-2.69-33.54
Free Cash Flow
-51.89-37.53-36.28
Free Cash Flow Per Share
-4.84-22.43-21.70
Cash Interest Paid
1.421.160.13
Levered Free Cash Flow
-34.21-27.91-
Unlevered Free Cash Flow
-32.73-23.04-
Change in Net Working Capital
-9.36-4.2-
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q